Skip to content
Basket 0

Your basket is empty.

View basket
☰

Decadron

Decadron
In stock
0,5mg
from 17,96 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
21,55 £ 17,96 £
0,60 £ per tablet

In brief

  • Decadron (dexamethasone) is a prescription-only medicine (POM) in the UK.
  • Decadron is used to treat inflammation, allergic reactions, autoimmune conditions, cerebral oedema, some cancer-related indications and as an antiemetic; it is a potent glucocorticoid that binds the glucocorticoid receptor and modifies gene transcription to reduce inflammation and suppress immune responses.
  • Usual oral doses range from 0.5–9 mg/day for inflammatory conditions (higher doses, eg 24–40 mg/day, may be used in severe cases); specific regimens include 6 mg daily for severe COVID‑19, 10 mg IV then 4 mg IV/IM every 6 hours for cerebral oedema, and oncology protocols such as 40 mg on defined cycles—paediatric dosing is weight-based (eg 0.02–0.3 mg/kg/day).
  • Available forms include tablets, oral solution, injectable vials/ampoules, eye drops and ophthalmic implants.
  • Oral dexamethasone typically begins to take effect within about 1–2 hours; IV administration can produce more rapid effects (within minutes to an hour) for acute indications.
  • It is a long-acting corticosteroid — clinical effects can persist for 24–72 hours and the biological half-life is roughly 36–54 hours, so dosing is often once daily or as directed by a prescriber.
  • Avoid or limit alcohol — alcohol may increase gastrointestinal irritation, worsen immunosuppression and interact with metabolic side effects such as hyperglycaemia.
  • The most common side effect is insomnia (other frequent effects include mood changes, increased appetite, indigestion, headache and fluid retention).
  • Would you like to try Decadron without a prescription?

Basic Decadron information

  • INN (international nonproprietary name): Dexamethasone
  • Brand names available in the United Kingdom: Decadron; Dexamethasone (tablets, oral solution, ampoules/vials)
  • ATC code: H02AB02
  • Forms & Dosages: Tablets 0.5 mg, 0.75 mg, 1 mg, 2 mg, 4 mg, 6 mg, 8 mg; oral solution 0.5 mg/5 mL, 1 mg/mL, 4 mg/mL; injectable solution 4 mg/mL, 10 mg/mL; eye drops 0.1%; ophthalmic implant 700 mcg (Ozurdex)
  • OTC / Rx classification: Prescription-only medicine (POM) in the UK

Legal status and availability in the UK

In our online pharmacy Decadron is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

Clinical effectiveness in the UK

Dexamethasone remains a reliable short‑term option for symptom control across NHS acute care and oncology pathways when used at indication‑appropriate doses.

In respiratory failure it reduces need for escalation when given as per protocols.

Typical ICU/COVID regimen on the NHS is 6 mg daily for up to 10 days and cerebral oedema regimens start with 10 mg IV then 4 mg every 6 hours.

Outcome Timeframe Monitoring required
Symptom relief (inflammation) Hours–days Clinical review; blood glucose if at risk
Reduced ventilation/ICU need Days Ongoing respiratory observations
Neuro-oncology benefit (cerebral oedema) Immediate to 48 hours BP, glucose, neurological observations

On the NHS longer courses prompt glucose checks and bone health reviews to balance effectiveness against hyperglycaemia and osteoporosis risk.

Document dosing and rationale in e‑prescriptions and the NHS Summary Care Record for continuity of care.

Indications and expanded uses

Primary licensed indications include systemic inflammatory and allergic disorders, cerebral oedema and local ophthalmic therapies.

Off‑label uses commonly supported in NHS teams include antiemetic adjuncts in chemotherapy and peri‑operative inflammation control when documented.

  1. Primary indications: systemic inflammatory/allergic disorders; cerebral oedema; certain ophthalmic uses (including Ozurdex implant).
  2. Off‑label uses: chemotherapy antiemesis adjunct; peri‑operative inflammation control (local policy required).

Checklist for outpatient clinics: obtain informed consent for off‑label use; document rationale; record monitoring plan on the Summary Care Record.

Indication Typical dose Monitoring
Inflammatory / allergic 0.5–9 mg/day oral (severe up to 24–40 mg/day) Symptoms, glucose if risk factors
Cerebral oedema 10 mg IV then 4 mg IV/IM q6h Neurology, BP, glucose
Chemotherapy‑induced nausea prevention 8–12 mg for 1–4 days Anti‑nausea scores, glucose
Ophthalmic Topical 0.1% or Ozurdex 700 ”g implant IOP checks, visual acuity

Composition and brand landscape

The active ingredient is dexamethasone (INN) and the ATC code is H02AB02.

Dexamethasone is available as Decadron and as many generics in the form of tablets, oral solution and injectables.

Ozurdex is the trademarked ophthalmic implant containing 700 ”g dexamethasone.

Brand Form Strengths Typical pack sizes Manufacturer
Decadron Tablets / Injectable 0.5–8 mg; 4 mg/mL injectable 10 / 30 / 100 tablets; small vials Various (Merck, generics)
Generic dexamethasone Tablets / oral solution 0.5 mg/5 mL; 1 mg/mL; 4 mg/mL Bottles; blisters of 10/30/100 Teva, Hikma, Sun Pharma, others
Ozurdex Ophthalmic implant 700 ”g Single‑use implant Allergan

Common pack sizes include tablets in 10, 30 and 100 counts and oral solutions in measured bottles.

Decadron and other dexamethasone brands are prescription‑only medicines in the UK.

Contraindications and special precautions

What might make dexamethasone unsafe for someone?

Contraindication Clinical action
Known hypersensitivity to dexamethasone or excipients Do not prescribe; document allergy and choose alternative
Systemic fungal infections Avoid systemic steroids until infection treated
Live vaccines during therapy Defer live vaccines while on treatment

Relative contraindications requiring close NHS supervision include diabetes, peptic ulcer disease, osteoporosis, uncontrolled infections, psychiatric illness, glaucoma and significant hepatic or renal impairment.

Pharmacy counselling checklist:

  • Confirm allergies and current infections.
  • Check glucose history and advise monitoring if diabetic.
  • Warn about mood/behaviour changes and driving if affected.
  • Discuss minimising alcohol to reduce gastric irritation.

Pregnancy and breastfeeding require specialist input to weigh maternal benefit against fetal risk.

Dosage guidelines

Patients ask: how much will I be given and for how long?

Indication Adult typical dose Paediatric adjustment Monitoring
Inflammatory / allergic 0.5–9 mg/day (split doses) 0.02–0.3 mg/kg/day Symptoms, glucose if risk
Cerebral oedema 10 mg IV then 4 mg q6h Lower per weight/age Neurology, BP, glucose
Chemotherapy antiemetic 8–12 mg for 1–4 days Dosed by weight Nausea scores, glucose
COVID-19/ICU 6 mg daily up to 10 days Adjust in paediatrics Respiratory observations, glucose

Start elderly or hepatic/renal patients at the lower end and titrate according to response.

For courses longer than two weeks plan a gradual taper to avoid adrenal insufficiency.

Paediatric dosing must be calculated per kg with growth monitoring during repeated or prolonged exposure.

Interactions overview

Many patients worry about mixing drugs with steroids.

Dexamethasone interacts via enzyme induction, effects on potassium and glucose, and potentiation of GI risks with NSAIDs.

Severity Examples Action
Major Strong CYP3A4 inhibitors/inducers; anticoagulant therapy Review doses; monitor levels/INR and consider alternatives
Moderate Concomitant NSAIDs; hypokalaemic agents Advise gastroprotection; check K+; monitor for bleeding
Minor Stimulants, mild CYP interactions Monitor clinically

Alert: strong CYP3A4 inhibitors can increase steroid exposure and raise the risk of psychiatric events and hyperglycaemia; flag these pairs when reconciling medicines on PMR.

Pharmacists should run interaction checks on the patient medication record and recommend glucose, BP or potassium monitoring where indicated.

Comparable medicines and preferences

Clinicians wonder when to choose dexamethasone over other steroids.

Common comparators on the NHS are prednisolone, methylprednisolone, hydrocortisone and betamethasone.

Drug Relative potency vs dexamethasone Common uses Pros / cons
Prednisolone Less potent Chronic inflammatory conditions; easier tapering Good for oral tapering; less HPA suppression than dexamethasone per mg
Methylprednisolone Moderate potency IV pulses, exacerbations Useful IV formulations; flexible dosing
Hydrocortisone Low potency Adrenal replacement, acute adrenal crisis Preferred in adrenal insufficiency; short acting
Betamethasone Comparable/high potency Obstetric use, topical Strong anti‑inflammatory; similar HPA suppression risk

Dexamethasone’s high potency and long half‑life suit single‑daily dosing and specific oncology or neurological protocols, while others may be preferred when less HPA suppression or different PK is needed.

Frequently asked questions

Q: Can I stop dexamethasone suddenly?

A: Not for prolonged courses over two weeks; a taper is needed to avoid adrenal insufficiency.

Q: Is dexamethasone available without a prescription?

A: No – in the UK dexamethasone is a prescription-only medicine.

Q: Will it affect my blood sugar?

A: Yes; monitoring is required, especially for people with diabetes or at high metabolic risk.

Q: Can I have vaccines while on it?

A: Live vaccines are generally contraindicated during therapy; check with your GP or pharmacist for timing.

Symptom Action
Severe mood change or psychosis Contact GP or NHS 111 urgently
High blood glucose / dehydration Contact GP; consider urgent diabetes review
High fever or signs of infection Contact GP / 111 for assessment

Always record therapy on the NHS Summary Care Record and show prescriptions to your community pharmacist.

Guidelines for proper use

What should a pharmacist tell a patient receiving dexamethasone?

Confirm the indication, dose, duration and check for contraindications before supply.

  • Explain common adverse effects: insomnia, appetite increase, mood changes.
  • Advise missed dose: take as soon as possible the same day; do not double dose.
  • Stress tapering for courses longer than two weeks to avoid adrenal insufficiency.
  • Storage: store below 25°C, keep dry and away from light.

Provide a discharge checklist for clinic leaflets including medicine name (dexamethasone), strength/form, reason, duration/taper plan and monitoring schedule.

Red flags that require urgent review include very high fever, severe mood or behavioural changes, chest pain or severe hyperglycaemia.

Document the treatment and monitoring plan on the e‑prescription system and the NHS Summary Care Record to support continuity of care.

Delivery across the United Kingdom

City Region Delivery time
London England 9–21 days
Birmingham England 9–21 days
Manchester England 9–21 days
Glasgow Scotland 9–21 days
Leeds England 9–21 days
Liverpool England 9–21 days
Newcastle Upon Tyne England 9–21 days
Sheffield England 9–21 days
Bristol England 9–21 days
Edinburgh Scotland 9–21 days
Cardiff Wales 9–21 days
Belfast Northern Ireland 9–21 days
Nottingham England 9–21 days

Related products